Additional file 1: Table S1. of Noonan syndrome and Turner syndrome patients respond similarly to 4 years’ growth-hormone therapy: longitudinal analysis of growth-hormone-naïve patients enrolled in the NordiNet® International Outcome Study and the ANSWER Program
Peter Lee
Judith Ross
Birgitte Pedersen
Primoz Kotnik
John Germak
Henrik Christesen
10.6084/m9.figshare.c.3619061_D1.v1
https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_Table_S1_of_Noonan_syndrome_and_Turner_syndrome_patients_respond_similarly_to_4_years_growth-hormone_therapy_longitudinal_analysis_of_growth-hormone-na_ve_patients_enrolled_in_the_NordiNet_International_Outcome_Study_and_the_ANSWER_Progr/4387880
Estimated means (unadjusted) of HSDS for Noonan syndrome and Turner syndrome patients per year. Table S2. Estimated means (unadjusted) of ΔHSDS for Noonan syndrome and Turner syndrome patients from baseline. Table S3. Change in IGF-I SDS over time. (DOC 174 kb)
2015-09-08 05:00:00
Noonan syndrome
Turner syndrome
Human growth hormone